Aprepitant
Aprepitant · Antiemetic Supportive Agent (5-HT3 / NK1 Receptor Antagonist)
Indications & Uses
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Contraindications
Hypersensitivity to active ingredient or any formulation excipients.
Side Effects & Warnings
Headache, constipation, fatigue, QTc prolongation (5-HT3 antagonists).
Drug & Dietary Interactions
Caution with strong CYP3A inhibitors or inducers; review concurrent medications.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.